does tirzepatide increase heart rate and Rate: Clinical Effects and Monitoring UC Irvine researchers project cardiac

Zepbound (tirzepatide) is an FDA-approved prescription medication for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea

One section of the warning label links the possibility of AKI to severe dehydration from gastrointestinal distress like vomiting and diarrhea

If a substance is not approved for clinical use by any governmental regulatory authority and has performance enhancing potential, it may be prohibited under the S0 category

However, the effectiveness of Wegovy relies on creating a sustained calorie deficit alongside the medication's appetite-suppressing effects